No description available.

Menopause is the time in a womans life when regular menstrual periods cease, due to a natural change in sex hormones, which may be accompanied by unwelcome symptoms. PURPOSE: To determine whether physical activity is associated with a reduction in menopausal symptoms (hot flashes, insomnia, numbness, fatigue, headaches, psychological symptoms, urogenital symptoms and physical symptoms). Providing that symptom differences among activity levels exist, a secondary purpose was to suggest an adequate level of physical activity for relief of menopausal symptoms. METHODS: Women (n=401) who were not taking hormone replacement therapy completed two questionnaires based on a 7-day recall of an average week: the Leisure-Time Exercise Questionnaire (Godin & Shephard, 1985) and the Menopausal Index (St. Germain, Peterson, Robinson, & Alekel, 2001). Women were divided into quintiles according to their physical activity scores (1=least active, 5=most active) and compared for menopausal symptoms using first a MANCOVA with covariate percent fat, as this was the only covariate that had significant group mean differences. Secondly a MANOVA with the appropriate post-hoc analysis was conducted. RESULTS: The mean (SD) age of the participants was 58.2 (6.3), the mean years postmenopausal was 6.7 (6.0), the mean percent body fat was 37.4 (5.6) %, and 16.5% had a previous hysterectomy. Univariate tests did not identify significant group differences for hysterectomy (p=0.774) or time since menopause (p=0.440); however, there were significant group differences for percent body fat (p=0). The MANCOVA was not significant between physical activity groups with percent fat as a covariate (Wilks Lamda p = 0.126). The MANOVA indicated a significant group main effect of physical activity on menopausal symptoms (Wilks Lamda p = 0.034). Of the 8 symptoms under review there were significant group differences for fatigue (p=0.05), and physical symptoms (p=0.004). The post-hoc analyses identified that two least active groups reported above average fatigue occurrence whereas the three most active groups reported below average fatigue occurrence. Group 2 had significantly more physical symptom complaints than groups 4 & 5. Of the three symptoms comprising physical symptoms, there were significant differences for weight gain (p=0.004) but not for breast tenderness (p=0.742) or aches and pains (p=0.175). Groups 1 & 2 reported significantly higher frequency of weight gain than groups 4 & 5. CONCLUSION: Any indirect effect of physical activity on menopausal symptoms is most likely through the alteration of body composition. Women with lower percent body fat report less weight gain and fatigue. There was no significant relationship between physical activity levels and reporting of hot flashes/night sweats, insomnia, limb numbness, headache, psychological symptoms or urogenital symptoms. A randomized controlled clinical trial would likely determine the relationship between higher activity levels and symptom reduction. For future research it is recommended that groups be matched based on percent body fat prior to randomization and that a greater amount of physical activity be prescribed.

Menopause is the time in a womans life when regular menstrual periods cease, due to a natural change in sex hormones, which may be accompanied by unwelcome symptoms. PURPOSE: To determine whether physical activity is associated with a reduction in menopausal symptoms (hot flashes, insomnia, numbness, fatigue, headaches, psychological symptoms, urogenital symptoms and physical symptoms). Providing that symptom differences among activity levels exist, a secondary purpose was to suggest an adequate level of physical activity for relief of menopausal symptoms. METHODS: Women (n=401) who were not taking hormone replacement therapy completed two questionnaires based on a 7-day recall of an average week: the Leisure-Time Exercise Questionnaire (Godin & Shephard, 1985) and the Menopausal Index (St. Germain, Peterson, Robinson, & Alekel, 2001). Women were divided into quintiles according to their physical activity scores (1=least active, 5=most active) and compared for menopausal symptoms using first a MANCOVA with covariate percent fat, as this was the only covariate that had significant group mean differences. Secondly a MANOVA with the appropriate post-hoc analysis was conducted. RESULTS: The mean (SD) age of the participants was 58.2 (6.3), the mean years postmenopausal was 6.7 (6.0), the mean percent body fat was 37.4 (5.6) %, and 16.5% had a previous hysterectomy. Univariate tests did not identify significant group differences for hysterectomy (p=0.774) or time since menopause (p=0.440); however, there were significant group differences for percent body fat (p=0). The MANCOVA was not significant between physical activity groups with percent fat as a covariate (Wilks Lamda p = 0.126). The MANOVA indicated a significant group main effect of physical activity on menopausal symptoms (Wilks Lamda p = 0.034). Of the 8 symptoms under review there were significant group differences for fatigue (p=0.05), and physical symptoms (p=0.004). The post-hoc analyses identified that two least active groups reported above average fatigue occurrence whereas the three most active groups reported below average fatigue occurrence. Group 2 had significantly more physical symptom complaints than groups 4 & 5. Of the three symptoms comprising physical symptoms, there were significant differences for weight gain (p=0.004) but not for breast tenderness (p=0.742) or aches and pains (p=0.175). Groups 1 & 2 reported significantly higher frequency of weight gain than groups 4 & 5. CONCLUSION: Any indirect effect of physical activity on menopausal symptoms is most likely through the alteration of body composition. Women with lower percent body fat report less weight gain and fatigue. There was no significant relationship between physical activity levels and reporting of hot flashes/night sweats, insomnia, limb numbness, headache, psychological symptoms or urogenital symptoms. A randomized controlled clinical trial would likely determine the relationship between higher activity levels and symptom reduction. For future research it is recommended that groups be matched based on percent body fat prior to randomization and that a greater amount of physical activity be prescribed.

M.Tech. (Homoeopathy) / Please refer to full text to view abstract

Introdução: Os estágios da transição menopausal e pós-menopausa fazem parte do processo de envelhecimento ovariano, se caracterizam por alterações hormonais, principalmente o hipoestrogenismo, e o aparecimento de sintomas desconfortáveis e agravos à saúde. Entre os sintomas, as alterações na qualidade do sono vêm ganhando destaque pelo grande número de morbidade relacionada a este quadro. Objetivo: Estimar a prevalência da qualidade de sono ruim e caracterizar os fatores associados em mulheres na transição menopausal e pós-menopausa. Método: Estudo observacional de corte transversal com utilização de dados secundários, que investigou a qualidade do sono por meio do Índice de Qualidade do Sono de Pittsburgh (PSQI) em 875 mulheres de 35 a 65 anos selecionadas aleatoriamente e atendidas pelo Programa de Saúde da Família de Pindamonhangaba-SP. Para pesquisa dos fatores associados foram questionadas informações sócio-demográficas, hábitos de vida, história ginecológica e de morbidade clínica, uso de medicamentos, e realizadas medidas de peso, altura e circunferência abdominal. Foram feitas análises bivariadas e multivariadas, bem como criado um modelo de regressão logística múltipla no programa Stata 8.0, utilizando um intervalo de confiança de 95%. Resultados: O sono ruim esteve presente em 45,13% das participantes e os fatores associados foram: depressão (IC95%:3,37-6,88), síndrome do ovário policístico (IC95%: 1,17-2,83), atividade física ocupacional acima da média da população estudada (IC95%:1,12-2,19), uso de medicamentos que alteram a qualidade do sono (IC95%: 1,34-22,76), e como fator protetor, consumir até 3 doses de qualquer bebida alcoólica (IC95%: 0,28-0,77).Conclusão: A prevalência de sono ruim foi alta entre as mulheres na transição menopausal e pós-menopausa, e esteve associado a este quadro a presença de morbidade como depressão e síndrome do ovário policístico, o estilo de vida relacionado ao alto nível de atividade física ocupacional e o uso de medicamentos que alteram a qualidade do sono. / Introduction: The menopausal transition and postmenopause form part of the ovarian aging process and are characterized by hormonal alterations, principally hypoestrogenism, and the appearance of troublesome symptoms and deteriorations in health. Among the symptoms, changes in sleep quality are of particular note in view of the large number of morbidities related to this condition. Objective: To estimate the prevalence of poor sleep quality and characterize associated factors in women in the menopausal transition and postmenopause. Method: An observational, cross-sectional study carried out on secondary data using the Pittsburgh Sleep Quality Index (PSQI) to investigate sleep quality in 875 women of 35-65 years of age randomly selected among women receiving care in the Family Health Program in Pindamonhangaba, São Paulo. To evaluate associated factors, the sociodemographic data of the women were recorded and questions were asked regarding lifestyle habits, gynecological history, prior clinical morbidities and use of medication. Weight, height and abdominal circumference were measured. Bivariate and multivariate analyses were performed and a model of multiple logistic regression was created in the Stata software program, version 8.0, with a 95% confidence interval. Results: In 45.13% of participants, sleep quality was poor and other associated factors included depression (95%CI: 3.37-6.88), polycystic ovary syndrome (95%CI: 1.17-2.83), occupational physical activity above the average for the population studied (95%CI: 1.12-2.19), and use of medication that alters sleep quality (95%CI: 1.34-22.76). Consuming up to three doses of any alcoholic beverage per week was identified as a protective factor (95%CI: 0.28-0.77). Conclusion: The prevalence of poor quality sleep was high among women in the menopausal transition and postmenopause and was associated with the presence of morbidities such as depression and polycystic ovary syndrome, a lifestyle that includes a high level of occupational physical activity and the use of medication that alters sleep quality.

Objetivo: avaliar os efeitos do tratamento com o Trifolium pratense nos sintomas menopausais em mulheres climatéricas utilizando o Índice Menopausal de Kupperman (IMK) e pelo Inventário de Satisfação Sexual Golombok e Rust versão feminina (GRISS) l. Metodologia: Este estudo foi prospectivo, randomizado, duplo cego e controlado com placebo, e realizado no setor de Ginecologia Endócrina e Climatério da Disciplina de Ginecologia do Departamento de Obstetrícia e Ginecologia do Hospital das Clínicas, da Faculdade de Medicina da Universidade de São Paulo. Foram selecionadas 100 mulheres na faixa etária de 45 a 65 anos com sintomas menopausais, com amenorréia superior há 1 ano e sem tratamento nos últimos 6 meses. Após a seleção, as mulheres foram divididas em dois grupos: Grupo I (n = 50) receberam Trifolium pratense na dose de 40 mg, 1 capsula/dia, por via oral; Grupo II (n = 50) receberam placebo (controle), contendo lactose, 1 cápsula/dia por via oral. A duração do tratamento foi de 12 meses e as mulheres foram avaliadas antes do tratamento com quatro, oito e 12 meses de tratamento, por exames clínico e laboratorial. Aplicaram-se o teste de t Student e o ANOVA para avaliar as diferenças entre os grupos. Resultados: Houve melhora significante dos sintomas após quatro meses de tratamento no IMK, principalmente, as ondas de calores, em relação aos dados antes do tratamento nos dois grupos. Não observamos melhora na avaliação da sexualidade (GRISS). Conclusão: Nossos dados sugerem que o efeito da ministração de 40mg ao dia de Trifolium pratense pode não ser superior ao do placebo, na redução dos sintomas da pós-menopausa durante um ano de estudo / Objective: to evaluate the effects of Trifolium pratense treatment on the climacteric symptoms and sexualiy in postmenopausal women through Kuppermann Menopausal Index (KMI) and the Golombok Rust Inventory of Sexual Satisfaction (GRISS), respectively. Methods: This study was prospective, randomized, double-blind and placebo-controlled study. Hundred women were selected, aged between 45 and 65 years with climacteric symptoms, with menstruation absence (amenorrhea) that was more then one year and without any treatment for last six months. After selection, women were divided into two groups: GI (n = 50) received 40 mg Trifolium pratense (one capsule per day); GII (n = 50) received placebo (control, one capsule of lactose per day). The length of treatment was 12 months and women were evaluated before and after four, eight and twelve months of treatment through clinical and laboratorial exams. The t Student test and ANOVA were applied for analyzing the differences between groups. Results: There was significant ameliorate in the symptoms after four months of treatment through the KMI, mainly in hot flashes, compared to baseline data of both groups. The sexuality evaluation did not found any difference before and after treatment in both groups. Conclusion: Our data suggested that the 40 mg Trifolium pratense effect may be not superior than placebo in relation to decrease the postmenopausal symptoms during one year of study

Introdução - A ansiedade e depressão que acometem a mulher, na fase de transição menopausal e após menopausa, vêm sendo estudados, uma vez que estes agravos repercutem na qualidade de vida psicossocial da mulher. Objetivo - Estimar a prevalência da ansiedade e depressão e sua associação com a obesidade em mulheres na transição menopausal e após menopausa; e caracterizar os fatores associados à ansiedade e depressão.Métodos - Estudo observacional transversal com utilização de dados secundários, que investigou a ansiedade e depressão por meio de inventários, em 749 mulheres de 35 a 65 anos selecionadas aleatoriamente e atendidas pelo Programa de Saúde da Família de Pindamonhangaba-SP. O método consistiu na aplicação de um questionário auto-referido. Os fatores associados foram investigados por meio de informações sóciodemográficas, hábitos de vida, história ginecológica e obstétrica, morbidades, dados antropométricos e laboratoriais e uso de medicamentos. Foram feitas análises bivariadas e multivariadas, bem como criado um modelo de regressão logística múltipla no programa Stata 9.1, utilizando um intervalo de confiança de 95%. Resultados - A ansiedade esteve presente em 49,8% (IC95%:de 46,2% a 53,4%) e a depressão em 33,7% (IC95%: de 30,4% a 37,3%) das mulheres. A prevalência de obesas foi de 68,7%% (IC95%: de 65,3% a 72,0%). Não houve associação entre à obesidade e ansiedade, depressão. Os fatores associados a ansiedade foram: cintura abdominal superior a 80 cm (p=0,005), ser fumante (p=0,001), ter feito uso de TH (p=0,022), e renda superior a um salário mínimo (p=0,002). Quanto à depressão, os fatores que se associaram foram: qualidade de sono ruim (p=0,000), apnéia obstrutiva do sono (p=0,002) e os sentimentos de angústia (p=0,000) e insegurança (p=0,000). Conclusão - A prevalência de ansiedade foi alta atingindo metade das mulheres, a depressão atingiu mais de um terço das mulheres na transição menopausal e pós-menopausa, e não houve associação com a obesidade / Introduction - The anxiety and depression in women, during and after menopause, have been studied, once, of these damage echoes in the quality of the woman\'s life psychosocial. Objectives - Estimate the prevalence of the anxiety and depression and her association with the obesity in women in the transition menopausal and postmenopause; and to characterize the associated factors the anxiety and depression. Methods - An observational, cross-sectional study carried out on secondary data, that it investigated the anxiety and depression through inventories, in 749 women from 35 to 65 years randomly selected among women receiving care in the Family Health Program in Pindamonhangaba, São Paulo Brazil . The method consisted of the application of a solemnity-referred questionnaire, the associated factors were investigated through sociodemographic, information, lifestyle habits, gynecological and obstetric history, morbidities, given anthropometry and laboratories and use of medicines. They were made analyses bivariate and multivariate, were performed and a model of multiple logistic regression was created in the Stata software program, version 9.1, with a 95% confidence interval. Results - The anxiety was present in 49,8% (95%IC: 46,2%- 53,4%) and the depression in 33,7% (95%IC: 30,4%- 37,3%) of the women. The prevalence of obese was of 68,7% (95%IC: 65,3%-72,0%). there was not association between the obesity and anxiety, depression. Factors associated with anxiety were waist circumference greater than 80 cm (p=0,005), to be smoking (p=0,001), to have made use of TH (p=0,022), income above minimum wage (p=0,002). as for the depression the factors was associate with quality of sleep (p=0,000), obstructive apnea of the sleep (p=0,002) the anguish feelings (p=0,000) and insecurity (p=0,000). Conclusion - The anxiety prevalence was high in the half women\'s, the depression reached more than a third of the women in the transition menopausal and postmenopausal, and there was not association with the obesity

Introdução: A Incontinência Urinária (IU) é a perda involuntária de urina e, entre os fatores envolvidos no seu determinismo, a obesidade assume particular importância. Entretanto, ainda não está claro se o fator determinante é a gordura abdominal, mensurada pela medida da circunferência abdominal (CA), ou o excesso de gordura corpórea, avaliado pelo Índice de Massa Corpórea (IMC). Objetivos: Estimar a prevalência de IU em mulheres na transição menopausal e após a menopausa; verificar se há associação com o IMC e com a medida da CA em seu determinismo além de avaliar a qualidade de vida nas mulheres incontinentes estudadas. Métodos: Em estudo transversal, foram obtidos dados secundários a partir do banco de dados do Projeto de Saúde de Pindamonhangaba, pertencentes ao Programa de Saúde da Família, do referido Município. A população do estudo foram mulheres nos estágios da transição menopausal e pós menopausa, com idade entre 35 e 65 anos. Todas foram submetidas a uma entrevista sistematizada, que incluiu questões sobre perfil sociodemográfico, história ginecológica e obstétrica, incontinência urinária, morbidade e avaliações antropométricas, como altura, peso e medida da CA e coleta de sangue. Resultados: A prevalência da IU foi de 17,0 por cento e entre os fatores significativos associados ao seu determinismo incluíram-se episiotomia, religião evangélica, depressão, tabagismo atual, síndrome metabólica e medida da CA acima de 88 cm. Com relação à qualidade de vida das incontinentes, 16,1 por cento das mulheres relataram que a incontinência tem impacto na qualidade de vida e 3,2 por cento classificaram esse impacto como grave. Conclusão: A prevalência da IU foi menor em comparação a outros estudos, porém, constatou-se piora da qualidade de vida das incontinentes; com relação à obesidade, observou-se que a medida da CA maior que 88 cm se associou significativamente com a IU, o mesmo não ocorrendo com o IMC / ntroduction: Urinary Incontinence (UI) is the involuntary loss of urine and among the factors involved in its determinism, obesity takes particular importance. However, it is unclear whether the determinant factor is the abdominal fat measured by measuring the Abdominal Circumference (AC) and or the excess of body fat assessed by the Body Mass Index (BMI). Objectives: To estimate the prevalence of UI in women in menopausal transition and after menopause; check for an association between the BMI with the AC measure in its determinism and evaluate the quality of life in studied incontinent women. Methods: In cross-sectional study were obtained secondary data from the database of the Pindamonhangaba\'s Health Project, belonging to the Family Health Program of that municipality. The study population were women in transition and postmenopause stages, aged between 35 and 65. All were subjected to a systematic interview that included questions about Sociodemographic profile, obstetrical and gynecological history, urinary incontinence, morbidity and anthropometric measurements such as height, weight, AC measurement and blood collection. Results: The prevalence of U was 17.0 per cent and among the significant factors associated with its determinism is included episiotomy, evangelical religion, depression, current tabagistm, metabolic syndrome and CA measurement above 88 cm. Regarding the quality of life, 16.1 per cent of incontinent women reported having an impact on quality of life and 3.2 per cent classified it as severe. Conclusion: The prevalence of UI was lower compared to other studies, however, it was found a worsening in incontinents\' quality of life; in relation to obesity, it was observed that the measurement of AC > 88 cm was significativelly associated with UI, what was not observed for BMI

Introdução - A ansiedade e depressão que acometem a mulher, na fase de transição menopausal e após menopausa, vêm sendo estudados, uma vez que estes agravos repercutem na qualidade de vida psicossocial da mulher. Objetivo - Estimar a prevalência da ansiedade e depressão e sua associação com a obesidade em mulheres na transição menopausal e após menopausa; e caracterizar os fatores associados à ansiedade e depressão.Métodos - Estudo observacional transversal com utilização de dados secundários, que investigou a ansiedade e depressão por meio de inventários, em 749 mulheres de 35 a 65 anos selecionadas aleatoriamente e atendidas pelo Programa de Saúde da Família de Pindamonhangaba-SP. O método consistiu na aplicação de um questionário auto-referido. Os fatores associados foram investigados por meio de informações sóciodemográficas, hábitos de vida, história ginecológica e obstétrica, morbidades, dados antropométricos e laboratoriais e uso de medicamentos. Foram feitas análises bivariadas e multivariadas, bem como criado um modelo de regressão logística múltipla no programa Stata 9.1, utilizando um intervalo de confiança de 95%. Resultados - A ansiedade esteve presente em 49,8% (IC95%:de 46,2% a 53,4%) e a depressão em 33,7% (IC95%: de 30,4% a 37,3%) das mulheres. A prevalência de obesas foi de 68,7%% (IC95%: de 65,3% a 72,0%). Não houve associação entre à obesidade e ansiedade, depressão. Os fatores associados a ansiedade foram: cintura abdominal superior a 80 cm (p=0,005), ser fumante (p=0,001), ter feito uso de TH (p=0,022), e renda superior a um salário mínimo (p=0,002). Quanto à depressão, os fatores que se associaram foram: qualidade de sono ruim (p=0,000), apnéia obstrutiva do sono (p=0,002) e os sentimentos de angústia (p=0,000) e insegurança (p=0,000). Conclusão - A prevalência de ansiedade foi alta atingindo metade das mulheres, a depressão atingiu mais de um terço das mulheres na transição menopausal e pós-menopausa, e não houve associação com a obesidade / Introduction - The anxiety and depression in women, during and after menopause, have been studied, once, of these damage echoes in the quality of the woman\'s life psychosocial. Objectives - Estimate the prevalence of the anxiety and depression and her association with the obesity in women in the transition menopausal and postmenopause; and to characterize the associated factors the anxiety and depression. Methods - An observational, cross-sectional study carried out on secondary data, that it investigated the anxiety and depression through inventories, in 749 women from 35 to 65 years randomly selected among women receiving care in the Family Health Program in Pindamonhangaba, São Paulo Brazil . The method consisted of the application of a solemnity-referred questionnaire, the associated factors were investigated through sociodemographic, information, lifestyle habits, gynecological and obstetric history, morbidities, given anthropometry and laboratories and use of medicines. They were made analyses bivariate and multivariate, were performed and a model of multiple logistic regression was created in the Stata software program, version 9.1, with a 95% confidence interval. Results - The anxiety was present in 49,8% (95%IC: 46,2%- 53,4%) and the depression in 33,7% (95%IC: 30,4%- 37,3%) of the women. The prevalence of obese was of 68,7% (95%IC: 65,3%-72,0%). there was not association between the obesity and anxiety, depression. Factors associated with anxiety were waist circumference greater than 80 cm (p=0,005), to be smoking (p=0,001), to have made use of TH (p=0,022), income above minimum wage (p=0,002). as for the depression the factors was associate with quality of sleep (p=0,000), obstructive apnea of the sleep (p=0,002) the anguish feelings (p=0,000) and insecurity (p=0,000). Conclusion - The anxiety prevalence was high in the half women\'s, the depression reached more than a third of the women in the transition menopausal and postmenopausal, and there was not association with the obesity

Introdução: A Incontinência Urinária (IU) é a perda involuntária de urina e, entre os fatores envolvidos no seu determinismo, a obesidade assume particular importância. Entretanto, ainda não está claro se o fator determinante é a gordura abdominal, mensurada pela medida da circunferência abdominal (CA), ou o excesso de gordura corpórea, avaliado pelo Índice de Massa Corpórea (IMC). Objetivos: Estimar a prevalência de IU em mulheres na transição menopausal e após a menopausa; verificar se há associação com o IMC e com a medida da CA em seu determinismo além de avaliar a qualidade de vida nas mulheres incontinentes estudadas. Métodos: Em estudo transversal, foram obtidos dados secundários a partir do banco de dados do Projeto de Saúde de Pindamonhangaba, pertencentes ao Programa de Saúde da Família, do referido Município. A população do estudo foram mulheres nos estágios da transição menopausal e pós menopausa, com idade entre 35 e 65 anos. Todas foram submetidas a uma entrevista sistematizada, que incluiu questões sobre perfil sociodemográfico, história ginecológica e obstétrica, incontinência urinária, morbidade e avaliações antropométricas, como altura, peso e medida da CA e coleta de sangue. Resultados: A prevalência da IU foi de 17,0 por cento e entre os fatores significativos associados ao seu determinismo incluíram-se episiotomia, religião evangélica, depressão, tabagismo atual, síndrome metabólica e medida da CA acima de 88 cm. Com relação à qualidade de vida das incontinentes, 16,1 por cento das mulheres relataram que a incontinência tem impacto na qualidade de vida e 3,2 por cento classificaram esse impacto como grave. Conclusão: A prevalência da IU foi menor em comparação a outros estudos, porém, constatou-se piora da qualidade de vida das incontinentes; com relação à obesidade, observou-se que a medida da CA maior que 88 cm se associou significativamente com a IU, o mesmo não ocorrendo com o IMC / ntroduction: Urinary Incontinence (UI) is the involuntary loss of urine and among the factors involved in its determinism, obesity takes particular importance. However, it is unclear whether the determinant factor is the abdominal fat measured by measuring the Abdominal Circumference (AC) and or the excess of body fat assessed by the Body Mass Index (BMI). Objectives: To estimate the prevalence of UI in women in menopausal transition and after menopause; check for an association between the BMI with the AC measure in its determinism and evaluate the quality of life in studied incontinent women. Methods: In cross-sectional study were obtained secondary data from the database of the Pindamonhangaba\'s Health Project, belonging to the Family Health Program of that municipality. The study population were women in transition and postmenopause stages, aged between 35 and 65. All were subjected to a systematic interview that included questions about Sociodemographic profile, obstetrical and gynecological history, urinary incontinence, morbidity and anthropometric measurements such as height, weight, AC measurement and blood collection. Results: The prevalence of U was 17.0 per cent and among the significant factors associated with its determinism is included episiotomy, evangelical religion, depression, current tabagistm, metabolic syndrome and CA measurement above 88 cm. Regarding the quality of life, 16.1 per cent of incontinent women reported having an impact on quality of life and 3.2 per cent classified it as severe. Conclusion: The prevalence of UI was lower compared to other studies, however, it was found a worsening in incontinents\' quality of life; in relation to obesity, it was observed that the measurement of AC > 88 cm was significativelly associated with UI, what was not observed for BMI